Supplementary Figure S8 from Biomarkers Associated with Beneficial PD-1 Checkpoint Blockade in Non–Small Cell Lung Cancer (NSCLC) Identified Using High-Plex Digital Spatial Profiling

Abstract

A-B. PFS according to CD56+/CD3- cell counts in stroma (A) and CD56+/CD3+ cell counts in stroma (B); C-D. OS according to CD56+/CD3- cell counts in stroma (C) and CD56+/CD3+ cell counts in stroma (D)